About mitnewdigs

This author has not yet filled in any details.
So far mitnewdigs has created 8 blog entries.

Hilary Malone joins MIT NEWDIGS Executive Committee

Regulatory and business leader will help accelerate system-wide biomedical innovation

Dr Hilary MaloneCAMBRIDGE, MASSACHUSETTS, 1 MARCH 2017—The MIT New Drug Development Paradigms Initiative (NEWDIGS) announced today that Hilary Malone, Chief Regulatory Officer for pharmaceutical company Sanofi, has joined the NEWDIGS Executive Committee. Sanofi is a strategic partner of […]

MIT NEWDIGS Hosts Design Lab on Clinical Trial Innovation

Biomedical Innovation Initiative Supporting New NIH-Funded Trial Innovation Center

CAMBRIDGE, MASSACHUSETTS—The MIT NEW Drug Development ParadIGmS (NEWDIGS) initiative, an international biomedical innovation “think and do tank”, co-hosted an “Efficacy to Effectiveness Clinical Trial” Design Lab in partnership with the Tufts Clinical Translational Science Institute (CTSI) and the new Johns Hopkins University (JHU) – Tufts Medical Center […]

Kay Larholt joins MIT NEWDIGS as Director of Integrated Knowledge Solutions

Industry veteran will lead development of new decision support technologies

CAMBRIDGE, MASSACHUSETTS—The MIT New Drug Development Paradigms Initiative (NEWDIGS) announced today the hire of Dr. Kay M. Larholt as their Director of Integrated Knowledge Solutions. Dr. Larholt will lead a portfolio of activities focused on “Knowledge Generation and Use 2.0,” a critical component of Adaptive Biomedical […]

EVENT REPORT: MIT’s NEWDIGS Launches New Program in Healthcare Data

Data program focuses on facilitating the coordinated evolution of global data systems to more effectively reduce uncertainty in drug development and clinical decision-making.

The New Drug Development Paradigms Program (NEWDIGS) of the MIT Center for Biomedical Innovation has launched a program focused on driving greater value from healthcare data for patients, regulators, payers, and physicians. The […]

MIT’s NEWDIGS Launches New Program in Healthcare Data

The inaugural meeting of the NEWDIGS Data Program was held in January 2015, and brought together international experts from academia, government, information technology, and the healthcare sector. A series of panel discussions focused on identifying the gaps and opportunities that might be addressed through better international cooperation in data system design and use. Through discussion, […]

NEWDIGS 2015 Data Program Workshop

By invitation only
January 14-15, 2015


Adaptive pathways: a future approach to bring new medicines to patients?

December 12th, 2014

Scientists argue that scientific and political changes will make adaptive pathways the preferred approach to make new treatments available. “Adaptive pathways should be the preferred approach in the near future to bring new medicines to patients.” A number of scientists, including members of the European Medicines Agency (EMA) and its scientific Committees take this position in a co-authored article published in Clinical Pharmacology and Therapeutics.

NICE announces collaboration with NEWDIGS

November 21st, 2014

NICE (the UK National Institute for Health and Care Excellence) has joined a global group of organisations whose goal is to speed up the development and delivery of new, effective and affordable drugs to patients. The New Drug Development Paradigms (NEWDIGS) program, led by the Center for Biomedical Innovation (CBI) at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts brings together pharmaceutical companies, academic researchers, patient advocacy groups, government agencies involved in healthcare and other experts to collaborate on ways to reliably and sustainably deliver new, better, affordable therapeutics to the right patients faster.